ESOPREVEG LSR

ESOPREVEG LSR Capsules combine Esomeprazole 40 mg, a proton pump inhibitor (PPI), with Levosulpiride 75 mg (Sustained Release), a prokinetic agent, to provide effective relief from acid reflux, gastroesophageal reflux disease (GERD), gastritis, and functional dyspepsia. This dual-action formulation reduces excess stomach acid production while improving gastrointestinal motility, helping relieve symptoms such as heartburn, bloating, nausea, early satiety, and indigestion.

ESOPREVEG LSR Capsules are formulated to support digestive health by addressing both acid secretion and delayed gastric emptying, providing long-lasting relief from acid-related gastrointestinal disorders.

Key Benefits

• Provides effective relief from acidity and heartburn
• Helps manage GERD (Gastroesophageal Reflux Disease)
• Reduces excess stomach acid production
• Improves gastric motility and promotes faster stomach emptying
• Relieves bloating, nausea, and post-meal fullness
• Supports long-term digestive comfort and gastrointestinal health